OLIGOPEPTIDE LINKER INTERMEDIATE AND METHOD FOR PRODUCTION THEREOF Russian patent published in 2022 - IPC A61K47/64 A61K47/68 A61P35/00 C07K1/02 C07K5/06 C07K5/08 C07K5/10 

Abstract RU 2775973 C1

FIELD: chemistry.

SUBSTANCE: invention relates to a method for producing an oligopeptide linker intermediate by the formulas (1)-(3), wherein each of AA1, AA2, AA3, and AA4 is independently selected from a group consisting of the following: -valine- (-Val-), -citrulline- (-Cit-), -alanine- (-Ala-), -lysine- (-Lys-), -phenylalanine- (-Phe-), -glycine- (-Gly-), -leucine- (-Leu-), and -isoleucine- (-Ile-). The method includes: 1) conducting a condensation reaction between the carbonylation reagent, 2-(trimethylsilyl)ethanol, and amino acid AA1, then amino acid AA2, or consecutively amino acid AA1, amino acid AA2, and amino acid AA3, or consecutively amino acid AA1, amino acid AA2, amino acid AA3, and amino acid AA4, resulting in a 2-(trimethylsilyl)ethoxycarbonyl-oligopeptide condensation product; 2) interacting the resulting 2-(trimethylsilyl)ethoxycarbonyl-oligopeptide condensation product and para-aminobenzyl alcohol resulting in a condensation product constituting 2-(trimethylsilyl)ethoxycarbonyl-oligopeptide-para-aminobenzyl alcohol. The carbonylation reagent has a structure of the formula (5), wherein each of R1 and R2 is independently selected from the group of values specified under formula (5). The proposed method is performed in mild reaction conditions and ensures production of a highly pure product. Invention also relates to an application of the above method for producing an antibody-drug conjugate.

EFFECT: creation of an intermediate applicable in producing an antibody-drug conjugate.

(1),

(2),

(3),

wherein R1 and R2 are independently selected from a group consisting of:

,.

10 cl, 4 dwg, 1 tbl, 3 ex

Similar patents RU2775973C1

Title Year Author Number
ANTIBODY-DRUG CONJUGATE LOADED WITH BINARY TOXINS AND ITS USE 2021
  • Huang, Changjiang
  • Sun, Youxiang
  • Xiong, Jiukai
  • Kong, Nana
  • Yan, Xinxin
RU2795148C2
NEUROMEDIN AND SOMATOSTATIN RECEPTOR AGONISTS 2000
  • Sadat-Aalai Din
  • Morgan Barri A.
RU2263680C2
PEPTIDE DRUGS WITH HIGH EFFECTIVENESS AGAINST INSULIN RESISTANCE 2012
  • Nestor Dzhon Dzh.
RU2602801C2
NOVEL COMPOUND WITH EFFECTS OF THROMBOLYSIS, ACCEPTING FREE RADICALS AND DIRECTED ACTION ON THROMBUS, AS WELL AS METHOD FOR PRODUCTION AND USE THEREOF 2013
  • Peng Shiqi
  • Zhao Ming
  • Jiang Xueyun
RU2604193C2
ANTIBODY-DRUG CONJUGATES BASED ON ERIBULIN AND APPLICATION METHODS 2017
  • Albone, Earl, F.
  • Cheng, Xin
  • Custar, Daniel, W.
  • Furuuchi, Keiji
  • Li, Jing
  • Majumder, Utpal
  • Uenaka, Toshimitsu
RU2754369C2
ANTI-MESOTHELIN ANTIBODY AND CONJUGATE THEREOF WITH MEDICINAL PRODUCTS 2019
  • Fang, Jianmin
  • Huang, Changjiang
  • Jiang, Jing
  • Ye, Hui
  • Li, Shenjun
  • Xu, Qiaoyu
  • Luo, Wenting
  • Wang, Mingxue
RU2747995C1
UROTENSIN-II AGONISTS AND ANTAGONISTS 2001
  • Koj Dehvid Kh.
  • Rossovski Vojtsekh J.
RU2263679C2
LINKER FOR ANTIBODY-DRUG CONJUGATES AND THEIR USE 2019
  • Huang, Changjiang
  • Ye, Hui
  • Chen, Hu
  • Zhan, Xiuzhi
  • Shen, Nan
  • Luo, Wenting
  • Hou, Qiaohua
  • Fang, Jianmin
RU2792201C2
ANTI-CLAUDIN 18.2 ANTIBODY AND ITS ANTIBODY-DRUG CONJUGATE 2022
  • Fang, Jianmin
  • Li, Yuanhao
  • Zhu, Marie M.
  • Jiang, Jing
  • Shen, Yuelei
  • Li, Shenjun
  • Luo, Wenting
  • Zhang, Xiaoping
  • Wang, Lili
  • Wang, Ling
  • Zhang, Qinbin
  • Yang, Fang
RU2814164C2
TRI-, TETRA-, PENTA- AND POLYPEPTIDES AND THEIR THERAPEUTIC USE AS ANTIDEPRESSANT AGENT 1995
  • Genri B. Abadzhian
  • Dzhon F. Nobl
  • Dzhozef Dzh. Khlavka
RU2182910C2

RU 2 775 973 C1

Authors

Li Lele

Huang Changjiang

Dates

2022-07-12Published

2019-10-23Filed